Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
Bone Metastases
Brain Cancer
Business Management
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Genitourinary Cancers
Head & Neck Cancers
Hematologic Oncology
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Non-Hodgkin Lymphoma
Oncology Nursing News
Patient Resources
Sarcomas/TGCT
Special Reports in Personalized Cancer Care
Supportive Care
Online CME
Interactive Publications
SELECT A TOPIC
CURRENT VIEW
All Specialties
▲
Education ▲
Education ▼
Register
|
Login
Conference Coverage
Videos
NewsNetwork
OncLive
®
TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
Giants of Cancer Care
ISGIO
Webinars
OncLive Community
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
More >>
<< View more issues
OncologyLive - August 2012
Clinical Insights
Targeted Therapies May Have a Role in Urothelial Cancer
Targeted PD-1 Therapy Offers Opportunity to Sequence Agents
Rash Signals Better Outcome for Erlotinib Therapy in NSCLC
Cabozantinib Shows Promise as Potent RET Inhibitor in MTC
Study Will Evaluate Panitumumab Regimen in Advanced SCCHN
Clinical Insights Into Genitourinary Cancer
Cover Story
Drug Shortage Dilemma: Trying New Tactics in a Tough Arena
Features
On the Horizon for Multiple Myeloma: Update on Novel Agents, Bone Therapies
Bisphosphonates Remain Mainstays in Managing Bone Disease: Development of New Agents Is Continuing
From the Editor
Beyond the Basics: Unique Markers May Assist in Morphologic Classification
Pathways
ALK Inhibitors: Moving Rapidly From Discovery to Clinical Approval and Beyond
5 ALK-Related Questions for D. Ross Camidge, MD, PhD and Fredika M. Robertson, PhD
Science & Technology
“Male Lumpectomy” Emerges as New Option in Prostate Cancer: An Interview With E. David Crawford, MD
Evolving HCC Treatment Paradigm: Combinations and Sequencing
Publications
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
x
Subscribe